A detailed history of Glen Eagle Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Glen Eagle Advisors, LLC holds 175 shares of EMBC stock, worth $2,530. This represents 0.0% of its overall portfolio holdings.

Number of Shares
175
Holding current value
$2,530
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jul 03, 2024

BUY
$12.35 - $19.33 $2,161 - $3,382
175 New
175 $2.32 Million
Q2 2023

Aug 13, 2024

SELL
$21.6 - $30.69 $367 - $521
-17 Reduced 10.12%
151 $3.26 Million
Q1 2023

Aug 13, 2024

SELL
$23.07 - $32.77 $23 - $32
-1 Reduced 0.59%
168 $4.73 Million
Q3 2022

Aug 13, 2024

SELL
$24.0 - $33.42 $96 - $133
-4 Reduced 2.31%
169 $4.87 Million
Q2 2022

Aug 13, 2024

SELL
$24.78 - $33.36 $49 - $66
-2 Reduced 1.14%
173 $4.38 Million

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $836M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Glen Eagle Advisors, LLC Portfolio

Follow Glen Eagle Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Glen Eagle Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Glen Eagle Advisors, LLC with notifications on news.